uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted September 28, 2017

Seller of Prostate, Reishi Supplements Warned for Manufacturing Violations

On September 11, 2017, the FDA issued a warning letter to Vicare International (USA), Inc., following facility inspections which found a number of the company's products, including VI — DiabeCare, VI — Prosta Care, VI — Sheep Placenta, VI — Vessel Care II, VI — LiverCare, Nu — DiabeCare, Nu — Sheep Placenta, Nu — Prosta Care, Nu — Angio Care, Nu — LiverCare, Vicare Vi-Reishi, NuLife Nu-Reishi, and Vicare Super Cell to be adulterated because they were prepared, packed, or held under conditions that violate Current Good Manufacturing Practices for dietary supplements.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at